Shock, Cardiogenic Clinical Trial
Official title:
French Observatory on the Management of Cardiogenic Shock in 2016
Cardiogenic shock (CS) is defined as an organ hypoperfusion secondary to low cardiac output.
Catches diagnostic management, and therapeutic monitoring of these patients remain highly
variable from one center to another and even from one doctor to another within the same team.
The management protocols are often not standardized or non-existent.
It appears therefore necessary to make an inventory of the management practices of the CS in
France in 2016, prerequisite to a common work of standardization of practices and the
creation of specialized networks to support these complex patients.
The Observatory FRENSHOCK proposes to set up a cohort of 500 patients recruited prospectively
over a period of 6 months.
Patients will be followed up at 1 month and 1 year Patients should have agreed to participate
in the observatory, knowing that participation or refusal to participate will not alter the
therapeutic attitude of the physician responsible for the patient. The study of phenotypic
characteristics will not change the therapeutic approach of the medical teams.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04562272 -
Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP
|
N/A | |
| Completed |
NCT00420030 -
Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock
|
Phase 4 | |
| Completed |
NCT00000552 -
Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
|
Phase 3 | |
| Active, not recruiting |
NCT04079829 -
Postoperative Respiratory Abnormalities
|
||
| Completed |
NCT00157144 -
Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005
|
N/A | |
| Completed |
NCT03327493 -
Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMO
|
N/A | |
| Completed |
NCT02961439 -
Validation of Epworth Richmond's Echocardiography Education Focused Year
|
N/A | |
| Terminated |
NCT00112281 -
A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
|
Phase 3 | |
| Recruiting |
NCT05267886 -
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
|
Phase 4 | |
| Completed |
NCT04202432 -
Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac Output
|
||
| Completed |
NCT00491036 -
Intraaortic Balloon Pump in Cardiogenic Shock II
|
Phase 4 | |
| Terminated |
NCT00314847 -
Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardial Infarction Complicated With Cardiogenic Shock
|
Phase 4 | |
| Completed |
NCT03714048 -
Blood Management During ECMO for Cardiac Support
|
||
| Recruiting |
NCT06007963 -
Impella in Cardiogenic Shock Registry
|
||
| Completed |
NCT02697006 -
Synchronized Cardiac Assist for Cardiogenic Shock
|
||
| Active, not recruiting |
NCT02673931 -
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
|
N/A | |
| Recruiting |
NCT04643509 -
Validity of Cardiac Output Measurement Using Niccomo Device After Cardiac Surgery
|
||
| Recruiting |
NCT04224103 -
Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO)
|
||
| Completed |
NCT00604331 -
Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation
|
Phase 2 | |
| Completed |
NCT00417378 -
Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK)
|
Phase 4 |